NL7312270A - - Google Patents
Info
- Publication number
- NL7312270A NL7312270A NL7312270A NL7312270A NL7312270A NL 7312270 A NL7312270 A NL 7312270A NL 7312270 A NL7312270 A NL 7312270A NL 7312270 A NL7312270 A NL 7312270A NL 7312270 A NL7312270 A NL 7312270A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US287423A US3862190A (en) | 1972-09-08 | 1972-09-08 | 5-(unsubstituted and substituted phenoxy)-4-amino pyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7312270A true NL7312270A (xx) | 1974-03-12 |
Family
ID=23102839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7312270A NL7312270A (xx) | 1972-09-08 | 1973-09-06 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3862190A (xx) |
| JP (1) | JPS5543463B2 (xx) |
| AR (1) | AR202106A1 (xx) |
| AU (1) | AU471279B2 (xx) |
| BE (1) | BE804414A (xx) |
| CA (1) | CA996116A (xx) |
| CH (1) | CH581121A5 (xx) |
| DE (1) | DE2344611A1 (xx) |
| ES (1) | ES418567A1 (xx) |
| FI (1) | FI59796C (xx) |
| FR (1) | FR2198753B1 (xx) |
| GB (1) | GB1434805A (xx) |
| NL (1) | NL7312270A (xx) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941889A (en) * | 1972-09-08 | 1976-03-02 | Pfizer Inc. | 5-(Substituted phenoxy)-4-amino pyrimidines as anti-ulcer agents |
| JPS57164686U (xx) * | 1981-04-11 | 1982-10-16 | ||
| JPS6197973U (xx) * | 1984-12-03 | 1986-06-23 | ||
| JPS63135868U (xx) * | 1987-02-26 | 1988-09-06 | ||
| WO1998014430A1 (fr) * | 1996-10-02 | 1998-04-09 | Sumitomo Pharmaceuticals Co., Ltd. | Derives de pyrimidine |
| US6440965B1 (en) | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| US6583148B1 (en) * | 1999-04-08 | 2003-06-24 | Krenitsky Pharmaceuticals, Inc. | Neurotrophic substituted pyrimidines |
| ES2346513T3 (es) * | 2000-07-24 | 2010-10-18 | Krenitsky Pharmaceuticals, Inc. | 5-alquinil pirimidinas sustituidas que tienen actividad neurotrofica. |
| EP2657229B1 (en) | 2010-12-24 | 2016-03-30 | Nihon Nohyaku Co., Ltd. | Benzyloxypyrimidine derivative, agricultural/horticultural insecticide comprising said derivative and method for using the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB886693A (en) * | 1959-03-04 | 1962-01-10 | Ici Ltd | Heterocyclic compounds |
-
1972
- 1972-09-08 US US287423A patent/US3862190A/en not_active Expired - Lifetime
-
1973
- 1973-08-29 CA CA179,926A patent/CA996116A/en not_active Expired
- 1973-08-31 GB GB4121973A patent/GB1434805A/en not_active Expired
- 1973-09-04 BE BE1005334A patent/BE804414A/xx not_active IP Right Cessation
- 1973-09-05 CH CH1276273A patent/CH581121A5/xx not_active IP Right Cessation
- 1973-09-05 AU AU60031/73A patent/AU471279B2/en not_active Expired
- 1973-09-05 DE DE19732344611 patent/DE2344611A1/de not_active Withdrawn
- 1973-09-06 NL NL7312270A patent/NL7312270A/xx not_active Application Discontinuation
- 1973-09-07 FR FR7332346A patent/FR2198753B1/fr not_active Expired
- 1973-09-07 AR AR249980A patent/AR202106A1/es active
- 1973-09-07 FI FI2796/73A patent/FI59796C/fi active
- 1973-09-07 ES ES418567A patent/ES418567A1/es not_active Expired
- 1973-09-08 JP JP10158973A patent/JPS5543463B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FI59796C (fi) | 1981-10-12 |
| GB1434805A (en) | 1976-05-05 |
| ES418567A1 (es) | 1976-08-01 |
| FI59796B (fi) | 1981-06-30 |
| US3862190A (en) | 1975-01-21 |
| AU6003173A (en) | 1975-03-06 |
| AU471279B2 (en) | 1976-04-15 |
| JPS5543463B2 (xx) | 1980-11-06 |
| BE804414A (fr) | 1974-03-04 |
| FR2198753A1 (xx) | 1974-04-05 |
| CH581121A5 (xx) | 1976-10-29 |
| FR2198753B1 (xx) | 1976-09-03 |
| DE2344611A1 (de) | 1974-03-14 |
| AR202106A1 (es) | 1975-05-15 |
| JPS4992080A (xx) | 1974-09-03 |
| CA996116A (en) | 1976-08-31 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |